vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and Shoals Technologies Group, Inc. (SHLS). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $148.3M, roughly 1.0× Shoals Technologies Group, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 5.5%, a 2.3% gap on every dollar of revenue. On growth, Shoals Technologies Group, Inc. posted the faster year-over-year revenue change (38.6% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $-11.3M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 27.8%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
Shoals Technologies Group is a leading provider of electrical balance of systems solutions for renewable energy and e-mobility. It supplies connectivity components for solar projects, energy storage systems and EV charging infrastructure, serving clients across North America, Europe and Asia-Pacific.
NUTX vs SHLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $148.3M |
| Net Profit | $11.8M | $8.1M |
| Gross Margin | 30.4% | 31.6% |
| Operating Margin | 20.4% | 11.7% |
| Net Margin | 7.8% | 5.5% |
| Revenue YoY | -41.1% | 38.6% |
| Net Profit YoY | -80.8% | 3.9% |
| EPS (diluted) | $2.34 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $148.3M | ||
| Q3 25 | $267.8M | $135.8M | ||
| Q2 25 | $244.0M | $110.8M | ||
| Q1 25 | $211.8M | $80.4M | ||
| Q4 24 | $257.6M | $107.0M | ||
| Q3 24 | $78.8M | $102.2M | ||
| Q2 24 | $76.1M | $99.2M | ||
| Q1 24 | $67.5M | $90.8M |
| Q4 25 | $11.8M | $8.1M | ||
| Q3 25 | $55.4M | $11.9M | ||
| Q2 25 | $-17.7M | $13.9M | ||
| Q1 25 | $21.2M | $-282.0K | ||
| Q4 24 | $61.6M | $7.8M | ||
| Q3 24 | $-8.8M | $-267.0K | ||
| Q2 24 | $-364.0K | $11.8M | ||
| Q1 24 | $-364.0K | $4.8M |
| Q4 25 | 30.4% | 31.6% | ||
| Q3 25 | 57.8% | 37.0% | ||
| Q2 25 | 51.2% | 37.2% | ||
| Q1 25 | 55.9% | 35.0% | ||
| Q4 24 | 55.0% | 37.6% | ||
| Q3 24 | 27.8% | 24.8% | ||
| Q2 24 | 29.7% | 40.3% | ||
| Q1 24 | 15.1% | 40.2% |
| Q4 25 | 20.4% | 11.7% | ||
| Q3 25 | 48.7% | 13.7% | ||
| Q2 25 | 13.8% | 14.4% | ||
| Q1 25 | 38.1% | 5.4% | ||
| Q4 24 | 44.4% | 15.4% | ||
| Q3 24 | 12.3% | 4.4% | ||
| Q2 24 | 7.0% | 18.7% | ||
| Q1 24 | 2.1% | 12.8% |
| Q4 25 | 7.8% | 5.5% | ||
| Q3 25 | 20.7% | 8.7% | ||
| Q2 25 | -7.3% | 12.5% | ||
| Q1 25 | 10.0% | -0.4% | ||
| Q4 24 | 23.9% | 7.3% | ||
| Q3 24 | -11.2% | -0.3% | ||
| Q2 24 | -0.5% | 11.9% | ||
| Q1 24 | -0.5% | 5.3% |
| Q4 25 | $2.34 | $0.05 | ||
| Q3 25 | $7.76 | $0.07 | ||
| Q2 25 | $-2.95 | $0.08 | ||
| Q1 25 | $3.33 | $0.00 | ||
| Q4 24 | $11.56 | $0.04 | ||
| Q3 24 | $-1.72 | $0.00 | ||
| Q2 24 | $-0.07 | $0.07 | ||
| Q1 24 | $-0.08 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $7.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $329.4M | $600.0M |
| Total Assets | $918.5M | $904.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | $7.3M | ||
| Q3 25 | $166.0M | $8.6M | ||
| Q2 25 | $96.7M | $4.7M | ||
| Q1 25 | $84.7M | $35.6M | ||
| Q4 24 | $40.6M | $23.5M | ||
| Q3 24 | $46.9M | $11.1M | ||
| Q2 24 | $40.8M | $3.2M | ||
| Q1 24 | $30.0M | $15.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $141.8M | ||
| Q4 24 | — | $141.8M | ||
| Q3 24 | — | $141.8M | ||
| Q2 24 | — | $146.8M | ||
| Q1 24 | — | $168.8M |
| Q4 25 | $329.4M | $600.0M | ||
| Q3 25 | $317.2M | $589.6M | ||
| Q2 25 | $235.3M | $575.4M | ||
| Q1 25 | $176.9M | $558.9M | ||
| Q4 24 | $132.4M | $556.8M | ||
| Q3 24 | $60.4M | $545.2M | ||
| Q2 24 | $62.7M | $544.6M | ||
| Q1 24 | $63.0M | $554.0M |
| Q4 25 | $918.5M | $904.1M | ||
| Q3 25 | $964.5M | $851.8M | ||
| Q2 25 | $841.0M | $795.0M | ||
| Q1 25 | $761.9M | $788.4M | ||
| Q4 24 | $655.3M | $793.1M | ||
| Q3 24 | $438.5M | $801.3M | ||
| Q2 24 | $422.4M | $788.4M | ||
| Q1 24 | $404.3M | $825.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.25× | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | 0.26× | ||
| Q2 24 | — | 0.27× | ||
| Q1 24 | — | 0.30× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $-4.1M |
| Free Cash FlowOCF − Capex | $69.0M | $-11.3M |
| FCF MarginFCF / Revenue | 45.5% | -7.6% |
| Capex IntensityCapex / Revenue | 0.9% | 4.8% |
| Cash ConversionOCF / Net Profit | 5.95× | -0.50× |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | $-16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | $-4.1M | ||
| Q3 25 | $99.5M | $19.4M | ||
| Q2 25 | $27.3M | $-13.8M | ||
| Q1 25 | $51.0M | $15.6M | ||
| Q4 24 | $54.0K | $14.0M | ||
| Q3 24 | $6.8M | $15.7M | ||
| Q2 24 | $13.3M | $37.8M | ||
| Q1 24 | $3.1M | $12.9M |
| Q4 25 | $69.0M | $-11.3M | ||
| Q3 25 | $99.2M | $9.0M | ||
| Q2 25 | $26.5M | $-26.0M | ||
| Q1 25 | $50.9M | $12.3M | ||
| Q4 24 | $-341.0K | $12.5M | ||
| Q3 24 | $6.2M | $13.3M | ||
| Q2 24 | $12.7M | $35.8M | ||
| Q1 24 | $2.3M | $10.4M |
| Q4 25 | 45.5% | -7.6% | ||
| Q3 25 | 37.0% | 6.6% | ||
| Q2 25 | 10.9% | -23.5% | ||
| Q1 25 | 24.0% | 15.4% | ||
| Q4 24 | -0.1% | 11.6% | ||
| Q3 24 | 7.8% | 13.0% | ||
| Q2 24 | 16.7% | 36.1% | ||
| Q1 24 | 3.4% | 11.4% |
| Q4 25 | 0.9% | 4.8% | ||
| Q3 25 | 0.1% | 7.7% | ||
| Q2 25 | 0.3% | 11.0% | ||
| Q1 25 | 0.0% | 4.0% | ||
| Q4 24 | 0.2% | 1.4% | ||
| Q3 24 | 0.8% | 2.3% | ||
| Q2 24 | 0.7% | 2.0% | ||
| Q1 24 | 1.1% | 2.7% |
| Q4 25 | 5.95× | -0.50× | ||
| Q3 25 | 1.80× | 1.63× | ||
| Q2 25 | — | -1.00× | ||
| Q1 25 | 2.40× | — | ||
| Q4 24 | 0.00× | 1.79× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.21× | ||
| Q1 24 | — | 2.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
SHLS
| System Solutions | $122.0M | 82% |
| Components | $26.3M | 18% |
